Allogene Therapeutics Inc
NASDAQ:ALLO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Allogene Therapeutics Inc
NASDAQ:ALLO
|
US |
|
C
|
Cheuk Nang Holdings Ltd
HKEX:131
|
HK |
|
M
|
ManpowerGroup Inc
F:MPW
|
US |
|
S
|
Studio Samick Co Ltd
KOSDAQ:415380
|
KR |
|
MTAR Technologies Ltd
NSE:MTARTECH
|
IN |
|
K
|
Kwung's Aroma Holdings Ltd
HKEX:1925
|
CN |
|
Shin Zu Shing Co Ltd
TWSE:3376
|
TW |
|
AudioEye Inc
NASDAQ:AEYE
|
US |
|
Airtel Africa PLC
F:9AA0
|
UK |
|
Austral Gold Ltd
ASX:AGD
|
AU |
|
S
|
SAMT Co Ltd
KOSDAQ:031330
|
KR |
|
J
|
Jaycorp Bhd
KLSE:JAYCORP
|
MY |
|
C
|
Chuan Hup Holdings Ltd
SGX:C33
|
SG |
|
Jullundur Motor Agency (Delhi) Ltd
NSE:JMA
|
IN |
|
Information Services Group Inc
NASDAQ:III
|
US |
|
Pradiksi Gunatama Tbk PT
IDX:PGUN
|
ID |
|
V
|
Verisk Analytics Inc
XMUN:VA7A
|
US |
|
Relo Group Inc
F:665
|
JP |
|
Manugraph India Ltd
NSE:MANUGRAPH
|
IN |
|
N
|
Nextin Inc
KOSDAQ:348210
|
KR |
|
B
|
Bioasis Technologies Inc
OTC:BIOAF
|
US |
|
Amarc Resources Ltd
XTSX:AHR
|
CA |
|
Kasen International Holdings Ltd
HKEX:496
|
HK |
|
P
|
Prodways Group SA
F:5PD
|
FR |
Bankruptcy Probability
Allogene Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Allogene Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Allogene Therapeutics Inc
NASDAQ:ALLO
|
614.7m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
454.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
204.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
178.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
57.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
82.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
47.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
43.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Allogene Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Allogene Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.